Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma

Lung cancer is a difficult-to-treat cancer. Lung adenocarcinoma (LUAD) is the main subtype of lung cancer. Although there are many ways to treat lung cancer, the survival rate of patients is low. Therefore, novel molecules need to be identified to diagnose and treat LUAD. This study utilized The Can...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Yufeng, Zheng, Zhong, Li, Sen, Yang, Guangyu, Qi, Fuwei, Fei, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553514/
https://www.ncbi.nlm.nih.gov/pubmed/36245990
http://dx.doi.org/10.1155/2022/5185202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553514/
https://www.ncbi.nlm.nih.gov/pubmed/36245990
http://dx.doi.org/10.1155/2022/5185202

Ejemplares similares